SDIX, (Nasdaq: SDIX ) is a biotechnology company,
expert at creating advantage by providing a broad range of quality,
innovative and effective immuno-solutions to the Pharmaceutical,
Biotechnology, Diagnostics, and Food Safety markets. For 20 years, SDIX
has developed antibodies which advance its customers’ immuno-based work -
reducing time, labor, and costs while increasing accuracy and
reliability of results.
SDIX offers a full suite of integrated immuno-solution capabilities
including assay design, development and production. In life science
markets, SDIX capabilities are being used to help discover the
mechanisms of disease, facilitate the development of new drugs, and
provide mechanisms for rapid diagnosis.
Quick Links:
Press Releases
EDGAR SEC filings
Corporate Governance
Annual Reports
Investor Presentations
Investor Relations Contacts
Email SDIX Investor
Relations
Transfer Agent
American Stock Transfer
Shareholder Services
59 Maiden Lane
Plaza Level
New York, NY 10038
800-937-5449